The STEP-HFpEF trial, in particular, found that semaglutide improved heart failure symptoms, walking distance, and overall quality of life in patients with HFpEF and obesity
Both Mounjaro and Zepbound injector pens and Zepbound single-dose vials don't contain preservatives and are approved for single-use only, so dose-splitting or microdosing is not contemplated by the FDA-label, the company notes
Accumulated evidence, indicate how bile acids are important modulators of the whole body metabolism, bridging the microbiome to the brain, likely being key signaling molecules in the pathogenesis of obesity and type 2 diabetes
This new fat may be distributed deeper under the skin, and it can be dangerous if it grows around the liver or heart
This is not just the case for clinical trials
Educational Notice: All information is provided solely for scientific and educational reference